Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Activator of HSP90 ATPase homolog 2, pseudogene (AHSA2P), is a human pseudogene and does not encode a functional protein. It is predicted, by sequence similarity, to potentially enable ATPase activator activity and may be involved in protein folding as a co-chaperone stimulating HSP90 ATPase activity. However, as a pseudogene, AHSA2P is not believed to be translated into a protein product or act as a direct therapeutic target. Functional paralogs/orthologs, such as AHSA1, are validated co-chaperones that stimulate HSP90 ATPase, but AHSA2P itself is not considered an active molecular target in pharmacology or disease.
None (no known drug interactions or mechanisms due to pseudogene status)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Activator of HSP90 ATPase homolog 2, pseudogene (AHSA2P).